Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sadanand Shetty
Observed names:
S R Shetty,
SADANAND R. SHETTY,
Sadanand R Shetty,
Sadanand R. Shetty,
SadanandR Shetty
Institution:
K. J. Somaiya Hospital & Research Centre
Observed institutions:
Ruby Hall Clinic,
USV (India),
DY Patil Deemed to be University,
K. J. Somaiya Hospital & Research Centre,
National Institute of Solar Energy,
K J Somaiya Medical College
show all 6
OpenAlex ID:
A5110042896
Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV
2024
·
Raman Puri
, Manish Bansal
, et al.
·
Journal of clinical lipidology
·
75
PDF
Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients
2015
·
Sadanand R. Shetty
, Soumitra Kumar
, et al.
·
Indian Heart Journal
·
45
PDF
Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of India
2022
·
Raman Puri
, Vimal Mehta
, et al.
·
Journal of clinical lipidology
·
30
Role of thrombolysis in reperfusion therapy for management of AMI: Indian scenario
2013
·
Jamshed Dalal
, Prasant Kumar Sahoo
, et al.
·
Indian Heart Journal
·
26
PDF
Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India
2022
·
Raman Puri
, Vimal Mehta
, et al.
·
Journal of clinical lipidology
·
22
Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry
2024
·
Guillaume Roger
, Grégory Ducrocq
, et al.
·
European Heart Journal
·
15
Unmet Need for Further LDL-C Lowering in India despite Statin Therapy: Lipid Association of India Recommendations for the Use of Bempedoic Acid
2022
·
Vimal Mehta
, Raman Puri
, et al.
·
Journal of the Association of Physicians of India
·
12
PDF
Lipoprotein(a) and ASCVD risk.
2020
·
Raman Puri
, Vimal Mehta
, et al.
·
PubMed
·
9
Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of India
2024
·
Raman Puri
, Vimal Mehta
, et al.
·
Journal of the Association of Physicians of India
·
7
Multidisciplinary Consensus for Rationalizing the Use of Acid Suppressants in Children and Adults: CONFOR
2024
·
Vijay Kher
, Manav Wadhawan
, et al.
·
Euroasian Journal of Hepato-Gastroenterology
·
7
PDF
Amlodipine and Landmark Trials: A Review
2021
·
Mohammed Yunus Khan
, Sadanand Shetty
, et al.
·
Journal of Cardiology and Cardiovascular Sciences
·
7
Non-HDL Cholesterol and Atherosclerotic Cardiovascular Disease.
2020
·
Raman Puri
, Vimal Mehta
, et al.
·
PubMed
·
7
Low Density Lipoprotein Cholesterol Targets in Secondary Prevention of Atherosclerotic Cardiovascular Disease.
2020
·
Raman Puri
, Vimal Mehta
, et al.
·
PubMed
·
7
Navigating Cardiovascular Risk and Lipid Management in Indian Patients: Key Messages from the Lipid Association of India 2024 Consensus Statement IV
2024
·
Raman Puri
, Vimal Mehta
, et al.
·
Journal of the Association of Physicians of India
·
6
Bempedoic Acid for Lipid Management in the Indian Population: An Expert Opinion
2023
·
Jagdish Hiremath
, J C Mohan
, et al.
·
Cureus
·
5
PDF
Low-Density Lipoprotein Cholesterol Goal Attainment in Indian Patients With Coronary Artery Disease
2026
·
Raman Puri
, Manish Bansal
, et al.
·
JACC Asia
·
4
PDF
Apolipoprotein B as a Predictor of CVD.
2020
·
Raman Puri
, Vimal Mehta
, et al.
·
PubMed
·
4
Lifestyle Modification in the Prevention of Atherosclerotic Cardiovascular Disease.
2020
·
Raman Puri
, Vimal Mehta
, et al.
·
PubMed
·
4
Triglycerides and Atherosclerotic Cardiovascular Disease.
2020
·
Raman Puri
, Vimal Mehta
, et al.
·
PubMed
·
4
Selective imidazoline receptor agonists: redefining role of centrally acting agents in role of centrally acting agents in management of hypertension
2019
·
Sadanand Shetty
, Anil Bhoraskar
, et al.
·
International Journal of Advances in Medicine
·
4
PDF
Angiotensin receptor neprilysin inhibitor in chronic heart failure and comorbidity management: Indian consensus statement
2024
·
Sanjay Mittal
, Sivadasanpillai Harikrishnan
, et al.
·
Therapeutic Advances in Cardiovascular Disease
·
3
Twenty-four-hour blood pressure management in India: A position statement by Indian College of cardiology
2020
·
PB Jayagopal
, BC Srinivas
, et al.
·
Journal of Indian College of Cardiology
·
2
Management of Hypertension and Associated Comorbidities: An Expert Consensus Statement from India
2025
·
HN Mishra
, Sadanand Shetty
, et al.
·
Journal of the Association of Physicians of India
·
1
Optimizing the Diagnosis and Management of Nocturnal Hypertension: An Expert Consensus from India
2025
·
H N Mishra
, Sadanand Shetty
, et al.
·
Journal of the Association of Physicians of India
·
1
Olmesartan: 360-degree Perspectives Befitting an Angiotensin Receptor Blocker
2024
·
Sadanand Shetty
, Anil Bhoraskar
, et al.
·
Journal of the Association of Physicians of India
·
1
Show more works
View as search
Works count:
32
Citation count:
312
H-index:
8
I10-index:
7
Year
Topic
Type